Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

New cytokine-targeted therapies show promise for treating alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

Upadacitinib effectively treats psoriasis and lichen planus together.

Pregnancy can cause skin changes and issues that need careful management.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Tattoos may trigger autoimmune symptoms in some people.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Obesity worsens skin health and losing weight can improve skin conditions.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Upadacitinib may effectively treat alopecia areata without side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.